Health

ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA

* ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. * Cellosome™ HA fillers are expected to be approved in 2023. * ExoCoBio has all 3 types of GMP clearance for pharmaceuticals, medical devices, & cosmetics. SEOUL, South Korea, March 2, 2023 /PRNewswire/ -...

2023-03-02 14:09 3673

Robert Walters China Salary Survey 2023: Easing of Epidemic Control: Recruitment Market Stabilises, Data Security and Compliance Talent being Key Recruitment Targets

SHANGHAI, March 2, 2023 /PRNewswire/ -- The government has announced the optimisation of the epidemic control measures, recruitment market is expected to rebound and gradually stabilise, according to theSalary Survey 2023 released byRobert Walters, one of the world-leading specialist professional...

2023-03-02 14:00 2326

DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY

Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor LAUSANNE, Switzerland, March 2, 2023 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), an independent Swiss-based, biopharmaceutical company ...

2023-03-02 09:00 2848

ClinChoice Acquires CROMSOURCE, Expanding its Global Presence

PHILADELPHIA, SHANGHAI and VERONA, Italy, March 2, 2023 /PRNewswire/ -- ClinChoice Medical Development is pleased to announce its acquisition of CROMSOURCE S.r.l., an ISO-certified full-service contract research organization with its corporate headquarters inVerona, Italy and its US headquarters ...

2023-03-02 04:12 3050

AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario

TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company inHamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated for high volum...

2023-03-01 22:00 1511

National Comprehensive Cancer Network Updates Annual Conference with New In-Person Venue, Hybrid Format, Expert-Led Sessions, Highlighted Research Perspectives, and Small-Group Conversations

Annual conference featuring more than a thousand worldwide oncology professionals will present new research findings, latest NCCN Guidelines updates, and best practices achieving quality cancer care delivery, inOrlando March 31—April 2, 2023. PLYMOUTH MEETING, Pa., March 1, 2023 /PRNewswire/ -- ...

2023-03-01 21:33 1675

The Sigourney Award Trust Issues Call For Entries Of Psychoanalytic Work Eligible To Win The Sigourney Award-2023

Applications For The Sigourney Award-2023 Accepted March 1 Through July 31 For International Recognition And Substantial Cash Prize SEATTLE, March 1, 2023 /PRNewswire/ -- The Sigourney Award Trust, founded by Mary Sigourney, annually honors individuals, groups or organizations with The Sigourney...

2023-03-01 21:20 1603

Maternity and Baby Brand Momcozy Launches 'Parachute Care Program' to Support Breastfeeding Journeys

NEW YORK, March 1, 2023 /PRNewswire/ -- Momcozy, the renowned maternity and baby brand endorsed by over 2 million moms globally, has announced the year-long Parachute Care Program  to support more moms' breastfeeding journeys. The brand has kicked off the first ...

2023-03-01 21:00 1829

GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting

SHANGHAI, March 1, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced today that European Medicine Agency (EMA) approved the phase Ib/II study of GFH925 (KRASG12C inhibitor) in combination wit...

2023-03-01 19:00 1908

Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year

EAST RUTHERFORD, N.J., March 1, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized with 2023 CDMO Leadership Awards in the categories of Quality, Service, Expertise, and Compatibility. Additionally...

2023-03-01 19:00 2307

Digital Transformation Across Life Sciences Industry Boosts Instrumentation Market

Automation and robotization to ensure industrywide streamlining and increase future growth potential SAN ANTONIO, March 1, 2023 /PRNewswire/ -- The development of next-generation sequencing (NGS) technology, a wide array of informatics, and robotics are some of the most recent technological adva...

2023-03-01 16:12 1951

FAT HOPE SHOU BE IT (FAT HOPE) Official Opens at Bugis Junction

Fat Hope Brings Korean Express Slimming Services to Singapore SINGAPORE, March 1, 2023 /PRNewswire/ -- FAT HOPE – SHOU BE IT (FAT HOPE) is proud to announce the official opening of its physical shop located at #03-05B, Bugis Junction, delivering the ultimate slimming experience to all clients. Th...

2023-03-01 15:48 2207

EW Nutrition showcases customer-focused solutions for the animal nutrition industry at VIV Asia 2023

SINGAPORE, March 1, 2023 /PRNewswire/ -- EW Nutrition will participate in VIV Asia 2023 to showcase its newest solutions for the animal nutrition industry. "We are constantly innovating to provide best-in-class products and programs. Our participation in VIV Asia 2023 is a good opportunity to con...

2023-03-01 14:10 2169

A promising picture for multi-cancer early detection in Southeast Asia - latest update from biotech firm Gene Solutions

HO CHI MINH CITY, Vietnam, March 1, 2023 /PRNewswire/ -- In January 2023, Vietnam's Medical Genetics Institute & Gene Solutions  published their research paper on Cancer Investigation:Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim re...

2023-03-01 09:30 2501

AMPLIFY HEALTH ASIA PTE LIMITED APPOINTS DR AXEL BAUR AS CHIEF EXECUTIVE OFFICER

* Dr Axel Baur succeeds Dr Jonathan Broomberg as Chief Executive Officer in planned succession as Amplify Health Asia Pte Limited accelerates its commercial strategy inAsia Pacific * Dr Broomberg will reassume his role as CEO of Vitality Health International and Global Head of Health Insuranc...

2023-03-01 09:00 2402

Sinclair launches Lanluma to battle cellulite and provide buttock reshaping

SINGAPORE, March 1, 2023 /PRNewswire/ -- Global aesthetics brand Sinclair introduced its latest addition, a collagen-stimulating injectable Lanluma at the Cellulite and Buttock Reshaping: My Experience with Lanluma®, Collagen Stimulating Injectable dinner talk on February 25. The event, attended b...

2023-03-01 08:00 1929

First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its IND application of its self-developed 9MW3811 injection for tumor and pulmonary fibrosis has been approved by the Therapeutic Goods Admi...

2023-02-28 23:00 1773

IMG Named a Best Travel Insurance Company of 2023 by Forbes Advisor

INDIANAPOLIS, Feb. 28, 2023 /PRNewswire/ -- International Medical Group® (IMG® ), an award-winning global insurance benefits and assistance services company, has been recognized for the second year in a row in the Forbes Advisor Best Of 2023 Awards category: Best Travel Insurance Companies Of 2023...

2023-02-28 22:00 1952

Global Cold Chain Transport Track & Trace Revenues in Pharma to Reach US$2.9 billion by 2027

For pharmaceutical companies to ensure product integrity and maintain regulatory compliance, deeper product monitoring, enhanced cold chain infrastructure, and focused automation will be critical NEW YORK, Feb. 28, 2023 /PRNewswire/ -- The global pharmaceutical (pharma) industry will surpassUS$1...

2023-02-28 21:30 1800

Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Oricell Therapeutics Co., Ltd ("Oricell" or "the Company"), aChina-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, today announced the close of a$45M Series B1 investment round after the completion ...

2023-02-28 21:00 2532
1 ... 262263264265266267268 ... 848